This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Zoom Rx recently polled HCPs and found 78% of physicians want to maintain some contact with pharmareps. The most desired informationdoctors now want is about patient assistance programs, with 49% saying they want pharmareps to provide that information. Where to start? Here are some options.
IN SUMMARY : When patients return to doctor’s offices will HCP’s have time to go online with every drug company that requests an online detail? Back to HCP’s…digitization can’t replace the relationships that pharmareps and MLS people build with doctors. As for patients?
Pharma companies are also helping patients understand where they can access labs, infusion centers, or imaging centers and offering solutions to HCPs and their practices so they can more easily afford and keep stock of therapies. And, in fact, 61% said they are interacting with pharma sales reps more during COVID-19 than they did before.
The resulting data offer a view into physician information needs at two critical junctures—during diagnosis and treatment selection. “We physicians are running into challenges around the diagnosis and treatment phase of specific diseases, and so express a need for information that will help them in each phase of the disease progression.”.
A decade ago, pharmareps could easily book in-person meetings with doctors, build lasting relationships, and crush their sales quotas. We have yet to talk about the increased level of competition that modern reps have to deal with. Today’s doctors don’t trust pharmaceutical sales reps as they once did.
Some of the questions we quizzed the physicians with focused on their thoughts around interactions with pharmareps. And the responses suggest an increasingly difficult future for the reps working in the EU5 markets. Fortunately, a lot of positive news is also coming out of our European research and the corresponding report.
Imagine spending weeks building trust with a doctor or pharmacist, only to find out that counterfeit versions of your product are circulating in the market. It’s a reality for many of us in pharma sales in Malaysia. Why This Hits Close to Home for PharmaReps As someone in pharma sales, this problem feels personal.
How Drug Access Programs Shape My Role As a pharmarep, I’ve seen the real, transformative impact of these programs. Initially, the doctors were skeptical about the program’s sustainability – and rightly so. For me, this experience was a powerful reminder that our role as reps goes far beyond sales.
How can we ensure that vital prescription information reaches patients when they need it? This is an achievable reality through strategic use of existing healthcare channels that have been negotiated for pharma access—inside the electronic health record (EHR).
Pharmaceutical representatives (pharmareps) are facing new challenges as a result of these transformations that have drastically altered the pharmaceutical sales landscape. Essential Competencies in Pharmaceutical Sales First, let’s review the competencies of a successful sales rep in pharma.
Pharmaceutical Sales refers to selling prescription and over-the-counter (OTC) medications, medical devices, and other healthcare products to healthcare professionals, or medical providers such as doctors, pharmacists, and hospitals. You must be able to convey complex medical information to healthcare professionals clearly and engagingly.
Imagine what a pharmarep will look like in 10 years. Or perhaps they’ll be engaging with doctors in virtual reality. We want to put what they need right at their fingertips to get more done in this information-rich environment without getting lost or distracted in the software.
Point-of-Care marketers had to make a lot of adjustments as the pandemic completely upended the experience of patients seeing their doctor and getting their medications. When brands create messaging that removes stigmas and empowers patients to ask their doctor about a symptom that leads to a diagnosis, we have succeeded.
As pharmareps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. On average, HCPs viewed this medication’s approved information for approximately 32 seconds. THE CHALLENGE.
Finally, diving into the essentials of pursuing a career in electrophysiology med device sales, Keila highlights the need for a genuine curiosity to understand complex information and adaptability in this dynamic field. I’m guiding the doctor with his catheters while he is manipulating them and advising on where to make lesions.
Let’s get into that space because that’s a space that there isn’t enough information about as a whole. Ophthalmology offices opened quicker than most doctors’ or physicians’ offices did. I would say it’s equivalent probably to a pharmarep. Is that correct? What is ophthalmology?
A majority of HCPs want to receive relevant information on their own times and terms. A recent Sermo survey indicated that nearly two-thirds of responders changed their perception of medications or treatment options based on information obtained on social media. million self-identified HCPs on the platform to pharma marketers.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content